Literature DB >> 9833584

In vitro diagnosis of axillary lymph node metastases in breast cancer by spectrum analysis of radio frequency echo signals.

T Tateishi1, J Machi, E J Feleppa, R Oishi, J Jucha, E Yanagihara, L J McCarthy, T Noritomi, K Shirouzu.   

Abstract

Axillary lymph node status is of particular importance for staging and managing breast cancer. Currently, axillary lymph node dissection is performed routinely in cases of invasive breast cancer because of the lack of accurate noninvasive methods for diagnosing lymph node metastasis. We investigated the diagnostic ability of ultrasonic tissue characterization based on spectrum analysis of backscattered echo signals to detect axillary lymph node metastasis in breast cancer in vitro compared with in vitro B-mode imaging. Immediately after surgery, individual lymph nodes were isolated from axillary tissue. Each lymph node was scanned in a water bath using a 10-MHz instrument, and radio frequency data and B-mode images were acquired. Spectral parameter values were calculated, and discriminant analysis was performed to classify metastatic and nonmetastatic lymph nodes. Forty histologically characterized axillary lymph nodes were enrolled in this study, including 25 nonmetastatic and 15 metastatic lymph nodes. A significant difference existed in the spectral parameter values (slope and intercept) for metastatic and nonmetastatic lymph nodes. Spectral parameter-based discriminant function classification of metastatic vs. nonmetastatic lymph nodes provided a sensitivity of 93.3%, specificity of 92.0%, and overall accuracy of 92.5%. In comparison, B-mode ultrasound images of in vitro lymph nodes provided a sensitivity of 73.3%, specificity of 84.0%, and overall accuracy of 80.0%. Receiver operating characteristic (ROC) analysis comparing the efficacy of both methods gave an ROC curve area of 0.9888 for spectral methods, which was greater than the area of 0.8980 for B-mode ultrasound. Hence, this in vitro study suggests that the diagnostic ability of spectrum analysis may prove to be markedly superior to that of B-mode ultrasound in detecting axillary lymph node metastasis in breast cancer. Because of these encouraging results, we intend to conduct an investigation of the ability of spectral methods to classify metastatic axillary lymph nodes in vivo.

Entities:  

Mesh:

Year:  1998        PMID: 9833584     DOI: 10.1016/s0301-5629(98)00100-8

Source DB:  PubMed          Journal:  Ultrasound Med Biol        ISSN: 0301-5629            Impact factor:   2.998


  5 in total

1.  Ultrasonic tissue characterization via 2-D spectrum analysis: theory and in vitro measurements.

Authors:  Tian Liu; Frederic L Lizzi; Jeffrey A Ketterling; Ronald H Silverman; Gerald J Kutcher
Journal:  Med Phys       Date:  2007-03       Impact factor: 4.071

2.  Analysis of Two Quantitative Ultrasound Approaches.

Authors:  Pauline Muleki-Seya; Aiguo Han; Michael P Andre; John W Erdman; William D O'Brien
Journal:  Ultrason Imaging       Date:  2017-09-25       Impact factor: 1.578

3.  Lymph node characterization in vivo using endoscopic ultrasound spectrum analysis with electronic array echo endoscopes.

Authors:  R E Kumon; A Repaka; M Atkinson; A L Faulx; R C K Wong; G A Isenberg; Y-S Hsiao; M S R Gudur; C X Deng; A Chak
Journal:  Endoscopy       Date:  2012-05-25       Impact factor: 10.093

4.  Characterization of the pancreas in vivo using EUS spectrum analysis with electronic array echoendoscopes.

Authors:  Ronald E Kumon; Aparna Repaka; Matthew Atkinson; Ashley L Faulx; Richard C K Wong; Gerard A Isenberg; Yi-Sing Hsiao; Madhu S R Gudur; Cheri X Deng; Amitabh Chak
Journal:  Gastrointest Endosc       Date:  2012-04-11       Impact factor: 9.427

5.  In vivo characterization of pancreatic and lymph node tissue by using EUS spectrum analysis: a validation study.

Authors:  Ronald E Kumon; Michael J Pollack; Ashley L Faulx; Kayode Olowe; Farees T Farooq; Victor K Chen; Yun Zhou; Richard C K Wong; Gerard A Isenberg; Michael V Sivak; Amitabh Chak; Cheri X Deng
Journal:  Gastrointest Endosc       Date:  2009-11-17       Impact factor: 9.427

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.